Thus, low CUEDC2 expression is a risk factor that predicts poor survival, suggesting that decreased expression of CUEDC2 likely contributes to lung adenocarcinoma cell proliferation and might represent a prognostic biomarker for this disease. Here, CUEDC2 is linked to lung adenocarcinoma.